Jove
Visualize
Contact Us

Related Concept Videos

Drug Delivery: Overview01:16

Drug Delivery: Overview

827
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
827
Drug Delivery: Enteral Route01:18

Drug Delivery: Enteral Route

1.7K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.7K
Drug Delivery: Parenteral Route01:29

Drug Delivery: Parenteral Route

1.7K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.7K
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

810
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
810
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

3.3K
Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

7.1K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nanocellulose with dual carboxy and aldehyde functionality: a modular platform for hydrogel formation and sustained drug release.

Biomaterials science·2026
Same author

MAPK15 controls intracellular lipid uptake and protects mammalian liver from steatotic disease.

Hepatology communications·2026
Same author

Preclinical Application of Computer-Aided High-Frequency Ultrasound (HFUS) Imaging: A Preliminary Report on the In Vivo Characterization of Hepatic Steatosis Progression in Mouse Models.

Journal of imaging·2025
Same author

The Role of Canine Models of Human Cancer: Overcoming Drug Resistance Through a Transdisciplinary "One Health, One Medicine" Approach.

Cancers·2025
Same author

MAPK15 Prevents <i>IFNB1</i> Expression by Suppressing Oxidative Stress-Dependent Activation of the JNK-JUN Pathway.

International journal of molecular sciences·2025
Same author

MAPK15 controls mitochondrial fitness and contributes to prevent cellular senescence.

Autophagy reports·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jan 29, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
06:49

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

Published on: February 10, 2023

2.8K

Smart Cells Against Cancer: Advances in Cell-Based Drug Delivery and Diagnostics.

Lisa Gherardini1, Giovanni Inzalaco2, Sara Gargiulo1

  • 1Istituto di Fisiologia Clinica (IFC), Consiglio Nazionale delle Ricerche (CNR), 53100 Siena, Italy.

Pharmaceutics
|January 28, 2026
PubMed
Summary

Cell-based drug delivery uses cells to transport anticancer agents, improving cancer treatment efficacy and reducing side effects. This approach enhances drug targeting and circulation, particularly for brain tumors.

Keywords:
cancercellular carrierdrug deliveryglioblastoma

More Related Videos

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
10:37

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells

Published on: August 22, 2025

1.2K
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

26.1K

Related Experiment Videos

Last Updated: Jan 29, 2026

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer
06:49

Orthotopic Implantation of Patient-Derived Cancer Cells in Mice Recapitulates Advanced Colorectal Cancer

Published on: February 10, 2023

2.8K
A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells
10:37

A Multimodal Imaging Framework to Advance Phenotyping of Living Label-free Breast Cancer Cells

Published on: August 22, 2025

1.2K
Preparation of Exosomes for siRNA Delivery to Cancer Cells
09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

26.1K

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Drug Delivery Systems

Background:

  • Cell-based drug delivery offers improved therapeutic targeting and reduced systemic toxicity for anticancer agents.
  • Conventional chemotherapy faces limitations due to off-target activity and non-specific distribution, leading to severe side effects.
  • Cellular carriers can evade immune clearance, prolong circulation, and enhance pharmacokinetic profiles for better therapeutic outcomes.

Purpose of the Study:

  • To review the current state of cell-mediated drug delivery in oncology.
  • To emphasize fundamental principles and practical applications of this therapeutic strategy.
  • To highlight innovations for theranostic potential, especially for challenging sites like the brain.

Main Methods:

  • Surveying the literature on cell-mediated drug delivery in cancer therapy.
  • Discussing the design and preparation of cellular carriers.
  • Examining characteristics of commonly used cell types and recent technological advancements.

Main Results:

  • Cellular carriers offer enhanced drug delivery, improved pharmacokinetics, and reduced toxicity in preclinical and clinical settings.
  • Specific cell types demonstrate unique advantages for drug delivery, including homing capabilities.
  • Technological innovations are expanding the potential of cell-based systems for targeted cancer treatment.

Conclusions:

  • Cell-based drug delivery represents a promising frontier in oncology, offering enhanced efficacy and safety.
  • Further research into cellular carrier design and optimization is crucial for clinical translation.
  • This strategy holds significant potential for treating challenging cancers, including those affecting the central nervous system.